Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Advancements in Therapeutic Diets Across the Oncology Nutrition MarketThe Oncology Nutrition Market Demand is experiencing a significant surge, with a projected market size reaching USD 30.97 billion by 2035. This trend reflects a growing recognition among healthcare professionals and patients alike of the critical role nutrition plays in cancer treatment and recovery. As cancer rates continue to rise globally, the demand for specialized nutritional solutions...0 Commenti 0 condivisioni 444 Views 0 Anteprima
-
BRICS Cancer Chemotherapy Market USD 6,140.1 Million in 2024 Projected to Witness Rapid Oncology Expansion to USD 14,315.4 Million by 2031Growing awareness of early cancer diagnosis and treatment is contributing to higher therapy uptake rates. The BRICS Cancer Chemotherapy Market is estimated to record a CAGR of 12.9% from 2025 to 2031. Cancer chemotherapy remains one of the most widely used treatment modalities for managing various types of cancer, including lung, breast, colorectal, and hematological malignancies. In BRICS...0 Commenti 0 condivisioni 578 Views 0 Anteprima
-
Can Next-Generation Oncology Treatments Strengthen the Taxane Market?According to the latest report published by Data Bridge Market Research, the Taxane Market CAGR Value The Taxane Market was valued at USD 5.50 billion in 2025 and is projected to reach USD 8.31 billion by 2033, growing at a CAGR of 5.30% from 2026 to 2033. The world-class Taxane Market report analyses some of the challenges that Taxane Market industry may have to face during the...0 Commenti 0 condivisioni 451 Views 0 Anteprima
-
Clinical Trials Market Growth Engine: Oncology and Precision MedicineThe global clinical trials market is entering a phase of accelerated expansion, as pharmaceutical and biotechnology companies race to bring new therapies to market faster and more efficiently than ever before. Regulatory bodies across major markets are actively encouraging decentralized and virtual trial models, patient populations are becoming more diverse and accessible through digital...0 Commenti 0 condivisioni 156 Views 0 Anteprima
-
Epigenetics-Based Therapeutics Market to Advance as Precision Oncology Research Expands" According to the latest report published by Data Bridge Market Research, the Epigenetics-Based Therapeutics Market CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The Epigenetics-Based...0 Commenti 0 condivisioni 494 Views 0 Anteprima
-
Generic Oncology Drugs Market 2034: Rising Demand for Cost-Effective Cancer MedicinesThe Generic Oncology Drugs Market is gaining importance as healthcare systems seek ways to manage cancer-treatment costs while maintaining access to essential medicines. Generic products are available across several oncology categories, including chemotherapy, hormonal therapy, targeted treatments, and supportive care. Their adoption is influenced by regulatory approval, clinical use,...0 Commenti 0 condivisioni 34 Views 0 Anteprima
-
Glioblastoma Multiforme Treatment Market Strengthens Through Breakthrough Oncology Innovations" According to the latest report published by Data Bridge Market Research, the Glioblastoma Multiforme Treatment Market CAGR Value Global glioblastoma multiforme treatment market size was valued at USD 3.09 billion in 2024 and is projected to reach USD 6.44 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032. An influential Glioblastoma Multiforme...0 Commenti 0 condivisioni 524 Views 0 Anteprima
-
Global Cancer API Market: Growing Oncology Drug Demand and Advanced API Manufacturing Drive Market ExpansionMarket Overview The Global Cancer API Market was valued at approximately USD 43.18 Billion in 2025 and is projected to reach nearly USD 62.63 Billion by 2032, expanding at a CAGR of 5.2% from 2026 to 2032. Cancer Active Pharmaceutical Ingredients (APIs) are essential components in medicines used to treat malignant diseases, and market development is being supported by increasing cancer...0 Commenti 0 condivisioni 11 Views 0 Anteprima
-
Global Fiducial Markers Market: Precision Oncology and Image-Guided Treatment Technologies Drive Market GrowthMarket Overview The Global Fiducial Markers Market was valued at approximately USD 121.80 Million in 2023 and is projected to reach nearly USD 162.46 Million by 2030, expanding at a CAGR of 4.2% from 2024 to 2030. Market growth is being supported by the increasing global cancer burden, wider use of radiotherapy, growing adoption of image-guided treatment, and advances in precision oncology....0 Commenti 0 condivisioni 28 Views 0 Anteprima
-
Global Post-CDK4/6 Treatment Line Oncology Drugs Market Report: Precision Oncology, Treatment Innovation and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market CAGR Value The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The...0 Commenti 0 condivisioni 605 Views 0 Anteprima
-
How Is Demand for Precision Oncology Supporting the Asia-Pacific Tumor Ablation Market?According to the latest report published by Data Bridge Market Research, the Asia-Pacific Tumor Ablation Market CAGR Value The Asia-Pacific tumor ablation market size was valued at USD 2.36 billion in 2025 and is expected to reach USD 5.61 billion by 2033, at a CAGR of 11.45% during the forecast period The reliable Asia-Pacific Tumor Ablation Market research report includes...0 Commenti 0 condivisioni 467 Views 0 Anteprima
-
Cancer Immunotherapy Market Growth Across Solid Tumors and Hematological MalignanciesThe global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Global Histiocytic Lymphoma Treatment Market Report: Targeted Therapy, Immunotherapy and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Histiocytic Lymphoma Treatment Market CAGR Value The global histiocytic lymphoma treatment market size was valued at USD 650.00 million in 2025 and is expected to reach USD 1,005.13 million by 2033, at a CAGR of 5.60% during the forecast period In this persuasive...0 Commenti 0 condivisioni 477 Views 0 Anteprima
-
How Is Genetic Risk Awareness Driving the North America Hereditary Cancer Testing Market?According to the latest report published by Data Bridge Market Research, the North America Hereditary Cancer Testing Market CAGR Value The North America hereditary cancer testing market size was valued at USD 3.39 billion in 2025 and is expected to reach USD 9.20 billion by 2033, at a CAGR of 13.3% during the forecast period Market research analysis and data in this North...0 Commenti 0 condivisioni 656 Views 0 Anteprima
-
Laryngeal Cancer Therapeutics Market: Global Pharmaceutical Companies, Oncology Treatment Solutions and Industry Growth Outlook"According to the latest report published by Data Bridge Market Research, the Laryngeal Cancer Therapeutics Market CAGR Value The global laryngeal cancer therapeutics market size was valued at USD 4.53 billion in 2025 and is expected to reach USD 6.44 billion by 2033, at a CAGR of 4.50% during the forecast period The Laryngeal Cancer Therapeutics Market analysis report...0 Commenti 0 condivisioni 301 Views 0 Anteprima
-
mTOR Inhibitor Oncology Drug Market Gains Momentum with Growing Targeted Cancer Therapy Pipeline" According to the latest report published by Data Bridge Market Research, the mTOR Inhibitor Oncology Drug Market CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Market research analysis and data...0 Commenti 0 condivisioni 488 Views 0 Anteprima
-
Oncology Based Molecular Diagnostics Market Outlook: Growing Adoption of Personalized Cancer TherapiesThe Oncology Based Molecular Diagnostics Market is rapidly evolving as precision medicine reshapes the global approach to cancer diagnosis and treatment. Molecular diagnostic technologies are enabling healthcare professionals to identify cancer-specific genetic alterations, detect tumors at earlier stages, and develop personalized treatment strategies based on individual patient...0 Commenti 0 condivisioni 577 Views 0 Anteprima
-
Oncology Cancer Drugs Market - Rising Cancer Prevalence and Technological Advancements in Targeted TherapiesThe Oncology Cancer Drugs Market is experiencing significant growth as rising cancer prevalence and technological advancements in targeted therapies and immunotherapies drive adoption across hospitals, cancer treatment centers, and research institutions. The Oncology Cancer Drugs Market is projected to grow from USD 210.43 billion in 2024 to USD 432.6 billion by 2032, exhibiting a compound...0 Commenti 0 condivisioni 260 Views 0 Anteprima
-
Primary Mediastinal Large B-cell Lymphoma Treatment Market: Global Analysis, Oncology Trends and Future OutlookAccording to the latest report published by Data Bridge Market Research, the Primary Mediastinal Large B-cell Lymphoma Treatment Market CAGR Value The global primary mediastinal large B-cell lymphoma treatment market size was valued at USD 850.00 million in 2025 and is expected to reach USD 1,354.77 million by 2033, at a CAGR of 6.00% during the...0 Commenti 0 condivisioni 409 Views 0 Anteprima
-
Primary Mediastinal Large B-Cell Lymphoma Treatment Market: Global Pharmaceutical Companies, Advanced Therapies and Industry Growth Outlook"According to the latest report published by Data Bridge Market Research, the Primary Mediastinal Large B-cell Lymphoma Treatment Market CAGR Value The global primary mediastinal large B-cell lymphoma treatment market size was valued at USD 850.00 million in 2025 and is expected to reach USD 1,354.77 million by 2033, at a CAGR of 6.00% during the forecast period The...0 Commenti 0 condivisioni 418 Views 0 Anteprima
-
Radiopharmaceutical Oncology Therapy Market Gains Traction with Advances in Targeted Radiation Treatment" According to the latest report published by Data Bridge Market Research, the Radiopharmaceutical Oncology Therapy Market CAGR Value The global radiopharmaceutical oncology therapy market size was valued at USD 5.43 billion in 2025 and is expected to reach USD 15.92 billion by 2033, at a CAGR of 14.40% during the forecast period To impart a...0 Commenti 0 condivisioni 520 Views 0 Anteprima
Pagine in Evidenza
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek